Conrado Fernández‐Rodríguez

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

Manuel Romero‐Gómez, María del Mar Viloria, Raúl J. Andrade et al. · Gastroenterology · 2005 · 730 citations · Full text

Metabolic Syndrome, Diabetes Management, Hepatology +12

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

Jordan J. Feld, Harald Hofer, Piero Luigi Almasio et al. · Journal of Hepatology · 2016 · 273 citations

Cirrhosis-related Complications, Epidemiology, Hepatology +12

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

Antoni Mas, Juan Rodés, Lourdes Sunyer et al. · Journal of Hepatology · 2002 · 255 citations

Hepatology, Liver Physiology, Pharmacology +6